JAK2 and acute lymphoblastic leukemia: In our case, the absence of shared driver mutations (JAK2/CALR/MPL in ET vs. SETD2/IKZF1 in ALL) supports clonal independence, consistent with prior reports of MPL- or JAK2-mutated ET progressing to Ph+ B-ALL (12, 13, 15).